Postmarketing Safety Study Tool: A Web Based, Dynamic, and Interoperable System for Postmarketing Drug Surveillance Studies

Postmarketing drug surveillance is a crucial aspect of the clinical research activities in pharmacovigilance and pharmacoepidemiology. Successful utilization of available Electronic Health Record (EHR) data can complement and strengthen postmarketing safety studies. In terms of the secondary use of EHRs, access and analysis of patient data across different domains are a critical factor; we address this data interoperability problem between EHR systems and clinical research systems in this paper. We demonstrate that this problem can be solved in an upper level with the use of common data elements in a standardized fashion so that clinical researchers can work with different EHR systems independently of the underlying information model. Postmarketing Safety Study Tool lets the clinical researchers extract data from different EHR systems by designing data collection set schemas through common data elements. The tool interacts with a semantic metadata registry through IHE data element exchange profile. Postmarketing Safety Study Tool and its supporting components have been implemented and deployed on the central data warehouse of the Lombardy region, Italy, which contains anonymized records of about 16 million patients with over 10-year longitudinal data on average. Clinical researchers in Roche validate the tool with real life use cases.

[1]  Thomas P. Gross,et al.  The US Food and Drug Administration's Sentinel Initiative: Expanding the horizons of medical product safety , 2012, Pharmacoepidemiology and drug safety.

[2]  F. Destefano,et al.  The Vaccine Safety Datalink project , 2001, Pharmacoepidemiology and drug safety.

[3]  E. Brown,et al.  The Medical Dictionary for Regulatory Activities (MedDRA) , 1999, Drug safety.

[4]  R. Platt,et al.  The new Sentinel Network--improving the evidence of medical-product safety. , 2009, The New England journal of medicine.

[5]  Jos De Roo,et al.  Demonstration of the SALUS Semantic Interoperability Framework for Case Series Characterization Studies , 2013, SWAT4LS.

[6]  Andrea J Cook,et al.  Methods for observational post-licensure medical product safety surveillance , 2015, Statistical methods in medical research.

[7]  Vaishali K. Patadia,et al.  Data Mining in Pharmacovigilance , 2005 .

[8]  D Kalra,et al.  Electronic health records: new opportunities for clinical research , 2013, Journal of internal medicine.

[9]  G. Niklas Norén,et al.  Duplicate detection in adverse drug reaction surveillance , 2007, Data Mining and Knowledge Discovery.

[10]  I. Pigeot,et al.  Signal Detection and Monitoring Based on Longitudinal Healthcare Data , 2012, Pharmaceutics.

[11]  S. Bakken,et al.  Development of a Customizable Health IT Usability Evaluation Scale. , 2010, AMIA ... Annual Symposium proceedings. AMIA Symposium.

[12]  Jeffrey G Klann,et al.  Query Health: standards-based, cross-platform population health surveillance , 2014, J. Am. Medical Informatics Assoc..

[13]  R. Platt,et al.  Developing the Sentinel System--a national resource for evidence development. , 2011, The New England journal of medicine.

[14]  YamamotoKeiichi,et al.  A pragmatic method for transforming clinical research data from the research electronic data capture REDCap to Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM) , 2017 .

[15]  Ali Anil Sinaci,et al.  A federated semantic metadata registry framework for enabling interoperability across clinical research and care domains , 2013, J. Biomed. Informatics.

[16]  Griffin M. Weber,et al.  Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) , 2010, J. Am. Medical Informatics Assoc..

[17]  Nigel Shadbolt,et al.  Resource Description Framework (RDF) , 2009 .

[18]  A Bate,et al.  Decision support methods for the detection of adverse events in post-marketing data. , 2009, Drug discovery today.